Gastroenterology News

Healio will present its seventh annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.

The FDA has approved the Stelara biosimilar Pyzchiva for psoriatic arthritis, Crohn’s disease and all other indications approved for the reference medicine, according to a press release from Sandoz.

Given the substantial investment to become a practicing physician, it should not be surprising that the most significant asset of most physicians is their ability to practice their profession.

Reintroduction of fructans and galacto-oligosaccharides was linked to worsened abdominal pain among patients with irritable bowel syndrome who had responded to the low-FODMAP diet, according to research.

In this video, Florence-Damilola Odufalu, MD, assistant professor of medicine at the University of Southern California, Keck School of Medicine, discusses family planning, pregnancy and managing inflammatory bowel disease.

Healio spoke with Florence-Damilola Odufalu, MD, assistant professor of medicine at the University of Southern California, Keck School of Medicine, about the future of inflammatory bowel disease and precision medicine.

Treatment for Helicobacter pylori infection was associated with reduced risk for gastric cancer among patients with a high genetic risk, suggesting that chemoprevention should be personalized to genetic risk, according to data.

The FDA granted marketing authorization for Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first rapid test for hepatitis C virus intended for use in point-of-care settings.

The U.S. Supreme Court ruled 5-4 on Thursday that members of the Sackler family cannot be protected from future lawsuits for their roles in the opioid epidemic.

Researchers have developed a data-driven, systematic approach for classification of the most potentially hepatotoxic medications based on incidence rates of severe acute liver injury, rather than published case report counts.